Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Colorectal Neoplasms

Free Subscription Articles published in Cancer Retrieve available abstracts of 51 articles: HTML format Text format

Single Articles

February 2010
1. SINICROPE F , Foster NR, Sargent DJ, Thibodeau SN, et al
   Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. SIENA S , Glynne-Jones R, Adenis A, Thaler J, et al
   Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. LEWIS C , Pignone M, Schild LA, Scott T, et al
   Effectiveness of a patient- and practice-level colorectal cancer screening intervention in health plan members: design and baseline findings of the CHOICE trial.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. AARTS F , Boerman OC, Sharkey RM, Hendriks T, et al
   Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')(2) antibody.
   Cancer. 2010;116.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. AUER RC , White RR, Kemeny NE, Schwartz LH, et al
   Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. TU SP , Sun YW, Cui JT, Zou B, et al
   Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. BLUMENTHAL DS , Smith SA, Majett CD, Alema-Mensah E, et al
   A trial of 3 interventions to promote colorectal cancer screening in African Americans.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. MCCLEARY NJ , Niedzwiecki D, Hollis D, Saltz LB, et al
   Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
9. DE HAAS RJ , Wicherts DA, Salloum C, Andreani P, et al
   Long-term outcomes after hepatic resection for colorectal metastases in young patients.
   Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. EDWARDS BK , Ward E, Kohler BA, Eheman C, et al
    Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SULTAN I , Rodriguez-Galindo C, El-Taani H, Pastore G, et al
    Distinct features of colorectal cancer in children and adolescents : a population-based study of 159 cases.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. PRINTZ C
    Aspirin may improve survival in colorectal cancer.
    Cancer. 2009;115:5365.
    PubMed     Text format     Related articles   
    
    
    November 2009
13. BERRY J , Caplan L, Davis S, Minor P, et al
    A black-white comparison of the quality of stage-specific colon cancer treatment.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. HINES RB , Shanmugam C, Waterbor JW, McGwin G Jr, et al
    Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
15. ZELL JA , Ziogas A, Bernstein L, Clarke CA, et al
    Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. KANNA B , Narang TK, Atwal T, Paul D, et al
    Ethnic disparity in mortality after diagnosis of colorectal cancer among inner city minority New Yorkers.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
17. SOLER-VILA H , Dubrow R, Franco VI, Saathoff AK, et al
    Cancer-specific beliefs and survival in nonmetastatic colorectal cancer patients.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. STEIN KD , Kaw C, Crammer C, Gansler T, et al
    The role of psychological functioning in the use of complementary and alternative methods among disease-free colorectal cancer survivors: a report from the American Cancer Society's studies of cancer survivors.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
19. HORST D , Budczies J, Brabletz T, Kirchner T, et al
    Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. WITTEKIND C , Compton C, Quirke P, Nagtegaal I, et al
    A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status.
    Cancer. 2009;115:3483-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. LIEBIG C , Ayala G, Wilks JA, Berger DH, et al
    Perineural invasion in cancer: a review of the literature.
    Cancer. 2009;115:3379-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. GARCIA-GRANERO E , Faiz O, Munoz E, Flor B, et al
    Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team.
    Cancer. 2009;115:3400-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
23. BOUCHAHDA M , Adam R, Giacchetti S, Castaing D, et al
    Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. MOSHER CE , Sloane R, Morey MC, Snyder DC, et al
    Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. VINCENZI B , Santini D, Russo A, Spoto C, et al
    Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. YAN B , Noone AM, Yee C, Banerjee M, et al
    Racial differences in colorectal cancer survival in the Detroit Metropolitan area.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. TU S , Wai-Yin Sun R, Lin MC, Tao Cui J, et al
    Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
28. SORBYE H , Pfeiffer P, Cavalli-Bjorkman N, Qvortrup C, et al
    Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. ERSIG AL , Hadley DW, Koehly LM
    Colon cancer screening practices and disclosure after receipt of positive or inconclusive genetic test results for hereditary nonpolyposis colorectal cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. MCLAFFERTY S , Wang F
    Rural reversal? Rural-urban disparities in late-stage cancer risk in Illinois.
    Cancer. 2009;115:2755-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. JIANG Y , Kimchi ET, Staveley-O'Carroll KF, Cheng H, et al
    Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. GOLD HT , Hal MJ, Blinder V, Schackman BR, et al
    Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. ZLOBEC I , Baker K, Minoo P, Hayashi S, et al
    Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. VARBAN O , Levine EA, Stewart JH, McCoy TP, et al
    Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. ISHIZAWA T , Fukushima N, Shibahara J, Masuda K, et al
    Real-time identification of liver cancers by using indocyanine green fluorescent imaging.
    Cancer. 2009;115:2491-504.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. LANSDORP-VOGELAAR I , van Ballegooijen M, Boer R, Zauber A, et al
    A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials.
    Cancer. 2009;115:2410-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
37. VAN BUREN G 2ND , Gray MJ, Dallas NA, Xia L, et al
    Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
38. SOTO-SALGADO M , Suarez E, Calo W, Cruz-Correa M, et al
    Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites, and non-Hispanic blacks in the United States, 1998-2002.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. JACKSON NA , Barrueco J, Soufi-Mahjoubi R, Marshall J, et al
    Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
40. WONG YN , Meropol NJ, Speier W, Sargent D, et al
    Cost implications of new treatments for advanced colorectal cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. HORST D , Reu S, Kriegl L, Engel J, et al
    The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. MULCAHY MF , Lewandowski RJ, Ibrahim SM, Sato KT, et al
    Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
43. GRAY SW , Armstrong K, Demichele A, Schwartz JS, et al
    Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. RIM SH , Seeff L, Ahmed F, King JB, et al
    Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. VILKIN A , Niv Y, Nagasaka T, Morgenstern S, et al
    Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
    Cancer. 2009;115:760-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. VAUTHEY JN , Zorzi D
    The patient behind the code, the care behind the patient.
    Cancer. 2009;115:702-3.
    PubMed     Text format     Related articles   
    
    
    
47. DILLMAN RO , Aaron K, Heinemann FS, McClure SE, et al
    Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. CHU E , Schulman KL, Zelt S, Song X, et al
    Costs associated with complications are lower with capecitabine than with 5-fluorouracil in patients with colorectal cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. PEETERS M , Siena S, Van Cutsem E, Sobrero A, et al
    Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
50. WATANABE T , Kobunai T, Sakamoto E, Yamamoto Y, et al
    Gene expression signature for recurrence in stage III colorectal cancers.
    Cancer. 2009;115:283-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
51. YU J , Tao Q, Cheng YY, Lee KY, et al
    Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: